Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
5.11
+0.03 (0.59%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| Distribution | 145.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Distribution Growth | 0.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Industrial | 3.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Industrial Growth | 21.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Retail | 2.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Retail Growth | 5.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Healthcare | 231.33M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Healthcare Growth | 6.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 115.13M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -27.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| China | 191.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 1.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 201.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 7.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Internal Offset | -40.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Internal Offset Growth | 2.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|